Dana Farber Cancer Institute Dept of Onc

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

ALK-activated Tumors

Studies at this site

• Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) — Completed